FDA OKs morning-after pill retail sale

August 24, 2006

Over-the-counter sale of Plan B, or the morning-after contraceptive pill was approved by the U.S. Food and Drug Administration Thursday.

In a statement, the agency said it will be available only to women 18 years old or older, and that a prescription would still be required for anyone younger.

Plan B contains the same ingredient used in prescription birth control pills, but a higher dose and the product has a different dosing regimen, the statement said.

When used as directed, it effectively and safely prevents pregnancy, the FDA said.

The drug will be marketed by Duramed, a subsidiary of Barr Pharmaceuticals.

Copyright 2006 by United Press International

Explore further: Novo Nordisk shares drop amid US pricing concerns

Related Stories

Novo Nordisk shares drop amid US pricing concerns

August 5, 2016

Shares in the world's largest maker of diabetes treatments, Novo Nordisk, fell more than eight percent on Friday after the company said prices were under pressure in the United States and lowered its growth forecast.

Senator renews scrutiny of pharma ties on federal panel

June 24, 2016

A high-ranking Senate Democrat is pushing for more answers on why doctors and patient advocates with financial ties to the pharmaceutical industry came to serve on a panel that advises the federal government on pain issues.

Recommended for you

Rosetta captures comet outburst

August 25, 2016

In unprecedented observations made earlier this year, Rosetta unexpectedly captured a dramatic comet outburst that may have been triggered by a landslide.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.